Safety and efficacy of eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer (ABC) patients. An Italian multicenter experienceE.S. Lutrino, Saverio Cinieri, Chiara Caliolo et al.|Annals of Oncology|2016Cited by 1
Safety of Eribulin plus Trastuzumab in pre-treated HER2-positive advanced breast cancer (ABC) patients: results from an Italian observational studyLaura Orlando, Saverio Cinieri, E.S. Lutrino et al.|Annals of Oncology|2016Cited by 0